AmeriFlex Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$480K Buy
1,889
+331
+21% +$77.1K 0.2% 103
2026
Q1
$381K Sell
1,558
-469
-23% -$109K 0.19% 112
2025
Q4
$419K Sell
2,027
-1,942
-49% -$384K 0.22% 101
2025
Q3
$736K Sell
3,969
-1,259
-24% -$216K 0.28% 70
2025
Q2
$795K Sell
5,228
-1,769
-25% -$272K 0.42% 53
2025
Q1
$1.16M Buy
6,997
+3,381
+94% +$529K 0.47% 48
2024
Q4
$550K Buy
+3,616
New +$560K 0.25% 89

Other funds holding JNJ

AmeriFlex Group's JNJ Position: Q2 2026 in Review

AmeriFlex Group increased its Johnson & Johnson (JNJ) stake by 21% in Q2 2026, buying an estimated $77.1K and bringing the position to 1,889 shares worth $480K. The position accounts for 0.2% of the portfolio, ranked #103.

AmeriFlex Group first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.16M in Q1 2025. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • AmeriFlex Group held 1,889 shares of Johnson & Johnson worth $480K as of Q2 2026.
  • AmeriFlex Group bought 331 Johnson & Johnson shares in Q2 2026, an estimated $77.1K.
  • Johnson & Johnson made up 0.2% of AmeriFlex Group's portfolio in Q2 2026, its #103 holding.
  • AmeriFlex Group first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • AmeriFlex Group's Johnson & Johnson position peaked at $1.16M in Q1 2025.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.